Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison Feb 12, 2024 8:34pm
249 Views
Post# 35876639

RE:RE:RE:Pfizer

RE:RE:RE:Pfizer Longholder99 wrote 

I don't doubt that at all.  Having a head start on multi indication treatment options using an FDA BTD approved drug, would leap frog any big Pharm over their xompetitors' Frankenstein class immuno manipulation drugs of the 90s.  What makes you think it though? 

Love your picturesque description Longholder99!  The conversation here is one that I have also read and have come to the same thought that Pfizer is overly hungry to acquire up and rising stars in cancer treatments but Merck shouldn't be ignored. Wait a minute what about others that can see their future markets affected by this upstart Theralase hmmm, could be more then the obvious bidders.
Ok question is will Theralase be bought out before the official trials end?
<< Previous
Bullboard Posts
Next >>